Prescription Drugs Global Market Report 2025

Description

Prescription drugs are medications that can only be obtained with a valid prescription from a licensed healthcare provider. These drugs are used to diagnose, treat, manage, or prevent various medical conditions under professional supervision, ensuring their appropriate use and reducing the risk of misuse or adverse effects.

Prescription drugs are categorized mainly into branded and generic types. Branded prescription drugs are marketed under a proprietary, trademarked name assigned by the pharmaceutical company that develops and patents the drug. They can be administered through various routes, including oral, topical, parenteral, and others. These drugs are used in a range of therapy areas, such as oncology, immunology, ophthalmology, respiratory, dermatology, gastroenterology, urology, gynecology, endocrinology, and more. The primary end users include hospitals, specialty clinics, homecare settings, and others.

The prescription drugs market research report is one of a series of new reports from the business research company that provides prescription drugs market statistics, including prescription drugs industry global market size, regional shares, competitors with an prescription drugs market share, detailed prescription drugs market segments, market trends and opportunities, and any further data you may need to thrive in the prescription drugs industry. This prescription drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prescription drug market size has grown rapidly in recent years. It will grow from $1289.77 billion in 2024 to $1430.3 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to the rising number of clinical trials, increasing availability of over-the-counter (OTC) products, rising need for daily prescriptions, rising healthcare costs, and increasing prevalence of several chronic disorders.

The prescription drug market size is expected to see rapid growth in the next few years. It will grow to $2145.22 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to a rising number of clinical trials, increasing availability of over the counter (OTC) products, rising need for daily prescriptions, rising healthcare costs, and increasing prevalence of several chronic disorders. Major trends in the forecast period include demand for biologic drugs, advances in genomics and data analytics, awareness of mental health issues, expansion of digital health, and a shift toward preventive medications.

The anticipated increase in drug production is expected to drive the growth of the prescription drug market in the future. Drug production involves the structured process of creating pharmaceutical products, including their formulation, testing, and packaging, to ensure quality, safety, and effectiveness. Expanding drug production is essential to meet the rising global demand for medications, tackle public health challenges, and ensure timely access to treatments for various medical conditions. Enhanced drug production can improve the availability, affordability, and innovation within the prescription drug market, ultimately benefiting patients and the healthcare system by improving access to essential medications and supporting better health outcomes. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based organization representing the pharmaceutical sector, reported significant production growth in the European pharmaceutical industry, with production rising from $352.48 billion in 2021 to $369.95 billion in 2022. Thus, the growth in drug production is expected to propel the development of the prescription drug market.

Major companies in the prescription drug market are focusing on developing alternatives to Victoza (liraglutide) or similar GLP-1 receptor agonist therapies to offer improved options for managing type 2 diabetes. Victoza is a brand-name medication containing liraglutide, a GLP-1 receptor agonist used primarily to treat type 2 diabetes in adults and children aged 10 and older. For example, in June 2024, Teva, an Israel-based pharmaceutical company, launched an authorized generic version of Victoza (liraglutide injection 1.8mg), providing a more affordable alternative while maintaining the same formulation, efficacy, and quality as the original branded drug. This launch is intended to increase access to essential diabetes treatments, offering cost-effective solutions for managing type 2 diabetes and reducing cardiovascular risks associated with the condition.

In November 2022, Alcon Inc., a Switzerland-based pharmaceutical company, acquired Aerie Pharmaceuticals Inc. for an undisclosed amount. This acquisition enhances Alcon's position in the pharmaceutical sector by broadening its portfolio of commercial products and expanding its pipeline of developmental drugs. Aerie Pharmaceuticals Inc., based in the US, specializes in prescription medications for patients with glaucoma and optic nerve diseases.

Major companies operating in the prescription drugs market are Pfizer Inc., Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Allergan plc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited

North America was the largest region in the prescription drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the prescription drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prescription drugs market consists of sales of bronchodilators, corticosteroids, combination inhalers, antibiotics, mucolytics, and biologics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prescription Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prescription drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prescription drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prescription drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Branded; Generics
2) By Route Of Administration: Oral; Topical; Parenteral; Other Routes Of Administration
3) By Therapy Area: Oncology; Immunology; Ophthalmology; Respiratory; Dermatology; Gastroenterology; Urology; Gynecology; Endocrinology; Other Therapy Areas
4) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Subsegments:
1) By Branded: Innovative Drugs; Patented Drugs; Blockbuster Drugs; Over-the-Counter (OTC) Prescription Drugs; Biosimilars; Specialty Drugs; Orphan Drugs; Combination Drugs
2) By Generics: Small Molecule Generics; Generic Biologics; Over-the-Counter (OTC) Generics; Authorized Generics; Generic Combination Drugs; High-Volume Generics; Generic Versions Of Blockbuster Drugs
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Private Limited; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33527

1. Executive Summary

2. Prescription Drugs Market Characteristics

3. Prescription Drugs Market Trends And Strategies

4. Prescription Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Prescription Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Prescription Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Prescription Drugs Market Growth Rate Analysis
5.4. Global Prescription Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Prescription Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Prescription Drugs Total Addressable Market (TAM)

6. Prescription Drugs Market Segmentation

6.1. Global Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Branded
Generic
6.2. Global Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
Parenteral
Other Routes Of Administration
6.3. Global Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Immunology
Ophthalmology
Respiratory
Dermatology
Gastroenterology
Urology
Gynecology
Endocrinology
Other Therapy Areas
6.4. Global Prescription Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End-Users
6.5. Global Prescription Drugs Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Innovative Drugs
Patented Drugs
Blockbuster Drugs
Over-the-Counter (OTC) Prescription Drugs
Biosimilars
Specialty Drugs
Orphan Drugs
Combination Drugs
6.6. Global Prescription Drugs Market, Sub-Segmentation Of Generics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Small Molecule Generics
Generic Biologics
Over-the-Counter (OTC) Generics
Authorized Generics
Generic Combination Drugs
High-Volume Generics
Generic Versions Of Blockbuster Drugs

7. Prescription Drugs Market Regional And Country Analysis

7.1. Global Prescription Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Prescription Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prescription Drugs Market

8.1. Asia-Pacific Prescription Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prescription Drugs Market

9.1. China Prescription Drugs Market Overview
9.2. China Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prescription Drugs Market

10.1. India Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prescription Drugs Market

11.1. Japan Prescription Drugs Market Overview
11.2. Japan Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prescription Drugs Market

12.1. Australia Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prescription Drugs Market

13.1. Indonesia Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prescription Drugs Market

14.1. South Korea Prescription Drugs Market Overview
14.2. South Korea Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prescription Drugs Market

15.1. Western Europe Prescription Drugs Market Overview
15.2. Western Europe Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prescription Drugs Market

16.1. UK Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prescription Drugs Market

17.1. Germany Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prescription Drugs Market

18.1. France Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prescription Drugs Market

19.1. Italy Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prescription Drugs Market

20.1. Spain Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prescription Drugs Market

21.1. Eastern Europe Prescription Drugs Market Overview
21.2. Eastern Europe Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prescription Drugs Market

22.1. Russia Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prescription Drugs Market

23.1. North America Prescription Drugs Market Overview
23.2. North America Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prescription Drugs Market

24.1. USA Prescription Drugs Market Overview
24.2. USA Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prescription Drugs Market

25.1. Canada Prescription Drugs Market Overview
25.2. Canada Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prescription Drugs Market

26.1. South America Prescription Drugs Market Overview
26.2. South America Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prescription Drugs Market

27.1. Brazil Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prescription Drugs Market

28.1. Middle East Prescription Drugs Market Overview
28.2. Middle East Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prescription Drugs Market

29.1. Africa Prescription Drugs Market Overview
29.2. Africa Prescription Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Prescription Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Prescription Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prescription Drugs Market Competitive Landscape And Company Profiles

30.1. Prescription Drugs Market Competitive Landscape
30.2. Prescription Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Prescription Drugs Market Other Major And Innovative Companies

31.1. Allergan plc
31.2. Bayer AG
31.3. Novartis AG
31.4. Sanofi SA
31.5. Bristol-Myers Squibb Company
31.6. AstraZeneca Plc
31.7. GlaxoSmithKline plc
31.8. Takeda Pharmaceutical Company Limited
31.9. Eli Lilly and Company
31.10. Boehringer Ingelheim International GmbH
31.11. Gilead Sciences Inc
31.12. Amgen Inc.
31.13. Viatris Inc.
31.14. Teva Pharmaceutical Industries Ltd.
31.15. Astellas Pharma Inc.

32. Global Prescription Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prescription Drugs Market

34. Recent Developments In The Prescription Drugs Market

35. Prescription Drugs Market High Potential Countries, Segments and Strategies

35.1 Prescription Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Prescription Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Prescription Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33527_Prescription_Drugs_GMR_2025